dihexa hgf c-met cancer risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Downstream signalling and specific inhibition

Third-party tested purity levels Batch-specific documentation Proper cold chain shipping Research compliance support Important: Always verify supplier credentials before purchasing peptides for research

Product Details Peptide Name: Cagrilintide Concentration: 10mg per vial Form: Lyophilized powder Purity: 99% (COA available) Use: For laboratory research only Manufactured in: GMP-certified facility Storage & Handling Store in a dry, cool location before reconstitution Store at -20C for extended preservation Notice This product is not for human or veterinary use

Animal studies have shown good tolerability across multiple administration routes including oral, intraperitoneal, intramuscular, and topical applications

Most experts recommend 4 to 8-week cycles rather than continuous use, as long-term human safety data is not available